Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (485)	2/9/1999 11:25:00 AM
From: Dr. John M. de Castro	Read Replies (2) \| Respond to of 1386

False alarm, the warrants are priced at $2.67. So, they will not be converted for a while. I received this information from Snppaigow who often posts on the Yahoo board but doesn't belong to SI. Thanks to him for the info. I had been unable to find the conversion price for the warrants in the 8K. He found them in: Form S-3/A for PHARMOS CORP filed on Jul 23 1998 edgar-online.com "(b) 500,000 shares of Common Stock issuable upon exercise of warrants held by CC Investments, LDC which are exercisable at $2.67 per share from February 3, 1999 to February 4, 2004, (c) 142,500 shares of Common Stock issuable upon exercise of warrants to purchase such shares at an exercise price of $2.28 per share by Gemini Capital, L.L.C. issued in connection with its role as placement agent for the Private Placement Transaction (which warrants are exercisable from February 3, 1999 until January 20, 2003), (d) 7,500 shares of Common Stock issuable upon exercise of warrants to purchase such shares at an exercise price of $2.28 per share held by Sara Kushnir issued in connection with R.D. Kushnir's role as placement agent for the Private Placement Transaction (which warrants are exercisable from February 3, 1999 until January 20, 2003), (e) 171,052 shares of Common Stock issuable upon exercise of warrants to purchase such shares at an exercise price of $1.38 per share by Alan Mark issued in connection with his role as placement agent for a private placement transaction completed in March 1997 (the "1997 Private placement Transaction")(which warrants are exercisable until March 31, 2008)"